2021 annual financial data
Immunome 2021 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -25,204,000 USD and net income was -24,711,000 USD.
Operating cash flow was -18,226,000 USD.
Get free Immunome email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -25,204,000 USD
- Net income
- -24,711,000 USD
- Operating cash flow
- -18,226,000 USD